
    
      This is a Phase II study using proton radiation therapy in addition to their standard care in
      subjects who have Stage I, IIA, IIB Seminoma. Testicular cancer are the most common solid
      cancers among men aged 20 to 35. Each subject must be 18 years of age or older and have a
      histologically proven diagnosis of testicular cancer. In addition to a subject's routine
      exams and tests, they will be asked to complete a series of quality of life questionnaires
      before, during and after their treatment. All side effects/toxicities will be monitored and
      recorded. Patients will be followed for a minimum of 5 years.
    
  